CareCloud, Inc.

NASDAQ:CCLD

Medical - Healthcare Information Services

Healthcare
$2.38 +1.60%

+$0.04 today

Market cap
$101.27M
Beta
1.51
P/E (TTM)
9.7
EPS (TTM)
$0.23
52W Low $2.09High $4.01

Volume 0.53M

Average 0.58M

CCLD EBITDA Margin

EBITDA as a percentage of revenue.

CareCloud, Inc.NASDAQ: CCLD

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 17.7%

EBITDA Margin was 17.7% in Q1 FY2026, down 2.0 pp from a year earlier. On a trailing-twelve-month basis it was 22.8%, up 1.3 pp year over year. Over 3 fiscal years it widened by 8.3 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 19.0% for the fiscal year ending Dec 2026, down from 23.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
17.7%-8.4 pp QoQ
Last fiscal yearDec 2025
23.5%+0.9 pp YoY
LTMMar 2026
22.8%+1.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-2.0 pp-2.4 pp-0.4 pp
1 year+0.9 pp-4.5 pp-5.3 pp
3 years+8.3 pp+0.5 pp-7.8 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
23.5%
Year-over-year change
+0.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How CCLD compares with its peers on the latest reported figures

  • CCLD's LTM Mar 2026 EBITDA Margin of 22.8% is the 2nd highest of the 8 companies compared; the peer median is -131.2%.
  • Its year-over-year change of +1.3 pp is the 7th highest of 8, against a peer median of +24.0 pp.
  • Over three fiscal years its change of +8.3 pp compares with a peer median of +175.4 pp.
CCLD Competitors Peer median
EBITDA Margin for CCLD and competitors
Company Period LTM level YoY 3-year change
AGENAgenus Inc.LTM Mar 2026102.6% +184.0 pp+219.6 pp
CCLDCareCloud, Inc.LTM Mar 202622.8% +1.3 pp+8.3 pp
JYNTThe Joint Corp.LTM Mar 20265.2% +4.5 pp-5.1 pp
APYXApyx Medical CorporationLTM Mar 2026-4.4% +24.0 pp+40.8 pp
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026-131.2% +8.9 pp+214.5 pp
SEERSeer, Inc.LTM Mar 2026-427.9% +95.5 pp+175.4 pp
LUCDLucid Diagnostics Inc.LTM Mar 2026-859.3% +600.4 pp+13170.1 pp
IRDOpus Genetics, Inc.LTM Mar 2026-874.0% -638.6 pp-384.3 pp
TTRXTurn Therapeutics Inc.FY2025— ——
HURATuHURA Biosciences, Inc.FY2025— ——
Peer median (excluding CCLD) -131.2%+24.0 pp+175.4 pp

Competitors are the stored peer set for CCLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue139.6M138.83M117.06M110.84M120.5M
Cost of Revenue86.92M84.43M70.82M60.84M64.46M
Gross Profit52.68M54.39M46.24M50M56.04M
Gross Margin37.7%39.2%39.5%45.1%46.5%
Research & Development4.41M4.4M4.74M3.78M6.38M
Selling, General & Admin33.06M33.61M31.11M22.36M23.2M
Operating Expenses49.15M47.78M93.36M40.87M44.55M
Depreciation & Amortization16.25M15.01M16.55M16.14M16.98M
EBITDA19.7M21.03M(31.29M)25.05M28.26M
EBITDA Margin14.1%15.1%-26.7%22.6%23.5%
Operating Income3.53M6.61M(47.12M)9.12M11.5M
Operating Margin2.5%4.8%-40.2%8.2%9.5%
Interest Income15K41K154K88K206K
Interest Expense455K405K1.19M900K287K
Other Income / Expenses(536K)(1M)(1.92M)(1.11M)(500K)
Income Before Tax2.99M5.61M(49.04M)8.01M11M
Pre-Tax Margin2.1%4.0%-41.9%7.2%9.1%
Income Tax Expense157K177K(364K)160K199K
Net Income2.84M5.43M(48.67M)7.85M10.8M
Net Margin2.0%3.9%-41.6%7.1%9.0%
EPS (Basic)(0.77)(0.67)(4.11)(0.28)0.10
EPS (Diluted)(0.77)(0.67)(4.11)(0.28)0.10
Weighted Avg Shares14.54M15.11M15.67M16.15M377.92M
Weighted Avg Shares (Diluted)14.54M15.11M15.67M16.15M379.54M

CareCloud, Inc.

NASDAQ:CCLD

Intrinsic Alpha fair value

Locked

Current Price

$2.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.